COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 3,120 | 173,327 | SH | | SOLE | | 173,327 | 0 | 0 |
ADAGIO THERAPEUTICS INC | COM | 00534A102 | 211 | 5,000 | SH | | SOLE | | 5,000 | 0 | 0 |
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 1,414 | 288,042 | SH | | SOLE | | 288,042 | 0 | 0 |
AFFIMED N V | COM | N01045108 | 292 | 47,182 | SH | | SOLE | | 47,182 | 0 | 0 |
AMRYT PHARMA PLC | SPONSORED ADS | 03217L106 | 6,218 | 516,221 | SH | | SOLE | | 516,221 | 0 | 0 |
ARCTURUS THERAPEUTICS HLDGS | COM | 03969T109 | 297 | 6,208 | SH | | SOLE | | 6,208 | 0 | 0 |
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 1,106 | 18,581 | SH | | SOLE | | 18,581 | 0 | 0 |
ARVINAS INC | COM | 04335A105 | 3,061 | 37,249 | SH | | SOLE | | 37,249 | 0 | 0 |
ATHIRA PHARMA INC | COM | 04746L104 | 998 | 106,388 | SH | | SOLE | | 106,388 | 0 | 0 |
AYALA PHARMACEUTICALS INC | COM | 05465V108 | 464 | 40,956 | SH | | SOLE | | 40,956 | 0 | 0 |
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 2,241 | 365,000 | SH | | SOLE | | 365,000 | 0 | 0 |
BENITEC BIOPHARMA INC | COM | 08205P100 | 1,778 | 498,009 | SH | | SOLE | | 498,009 | 0 | 0 |
BIOGEN INC | COM | 09062X103 | 1,242 | 4,389 | SH | | SOLE | | 4,389 | 0 | 0 |
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 8,598 | 61,897 | SH | | SOLE | | 61,897 | 0 | 0 |
CABALETTA BIO INC | COM | 12674W109 | 511 | 42,022 | SH | | SOLE | | 42,022 | 0 | 0 |
CALITHERA BIOSCIENCES INC | COM | 13089P101 | 406 | 186,245 | SH | | SOLE | | 186,245 | 0 | 0 |
CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 41 | 10,000 | SH | | SOLE | | 10,000 | 0 | 0 |
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 2,065 | 38,243 | SH | | SOLE | | 38,243 | 0 | 0 |
CERUS CORP | COM | 157085101 | 3,772 | 619,369 | SH | | SOLE | | 619,369 | 0 | 0 |
CHEMOCENTRYX INC | COM | 16383L106 | 2,380 | 139,200 | SH | Put | SOLE | | 139,200 | 0 | 0 |
COGENT BIOSCIENCES INC | COM | 19240Q201 | 5,701 | 677,900 | SH | | SOLE | | 677,900 | 0 | 0 |
COMPUGEN LTD | ORD | M25722105 | 1,215 | 203,532 | SH | | SOLE | | 203,532 | 0 | 0 |
COMPUGEN LTD | ORD | M25722105 | 1,481 | 248,000 | SH | Call | SOLE | | 248,000 | 0 | 0 |
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 1,039 | 49,382 | SH | | SOLE | | 49,382 | 0 | 0 |
CURIS INC | COM NEW | 231269200 | 486 | 62,070 | SH | | SOLE | | 62,070 | 0 | 0 |
CYBIN INC | COM | 23256X100 | 549 | 250,000 | SH | | SOLE | | 250,000 | 0 | 0 |
CYCLACEL PHARMACEUTICALS INC | COM | 23254L603 | 2,048 | 388,632 | SH | | SOLE | | 388,632 | 0 | 0 |
CYTOKINETICS INC | COM NEW | 23282W605 | 1,762 | 49,309 | SH | | SOLE | | 49,309 | 0 | 0 |
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 1,266 | 37,249 | SH | | SOLE | | 37,249 | 0 | 0 |
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 626 | 31,040 | SH | | SOLE | | 31,040 | 0 | 0 |
ELOXX PHARMACEUTICALS INC | COM | 29014R103 | 2,054 | 1,259,840 | SH | | SOLE | | 1,259,840 | 0 | 0 |
ERASCA INC | COM | 29479A108 | 1,976 | 93,122 | SH | | SOLE | | 93,122 | 0 | 0 |
EVELO BIOSCIENCES INC | COM | 299734103 | 434 | 61,700 | SH | Put | SOLE | | 61,700 | 0 | 0 |
EVOGENE LTD | SHS | M4119S104 | 656 | 248,327 | SH | | SOLE | | 248,327 | 0 | 0 |
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 1,347 | 129,290 | SH | | SOLE | | 129,290 | 0 | 0 |
FULCRUM THERAPEUTICS INC | COM | 359616109 | 5,238 | 185,691 | SH | | SOLE | | 185,691 | 0 | 0 |
GUARDANT HEALTH INC | COM | 40131M109 | 527 | 4,218 | SH | | SOLE | | 4,218 | 0 | 0 |
HALOZYME THERAPEUTICS INC | COM | 40637H109 | 2,448 | 60,170 | SH | | SOLE | | 60,170 | 0 | 0 |
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 2,224 | 223,906 | SH | | SOLE | | 223,906 | 0 | 0 |
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 5,747 | 52,469 | SH | | SOLE | | 52,469 | 0 | 0 |
IMMATICS N.V | SHS | N44445109 | 5,692 | 437,866 | SH | | SOLE | | 437,866 | 0 | 0 |
IMMUNOGEN INC | COM | 45253H101 | 3,685 | 649,919 | SH | | SOLE | | 649,919 | 0 | 0 |
INSMED INC | COM PAR $.01 | 457669307 | 4,808 | 174,588 | SH | | SOLE | | 174,588 | 0 | 0 |
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 664 | 4,950 | SH | | SOLE | | 4,950 | 0 | 0 |
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 3,798 | 101,890 | SH | | SOLE | | 101,890 | 0 | 0 |
ITEOS THERAPEUTICS INC | COM | 46565G104 | 3,157 | 116,931 | SH | | SOLE | | 116,931 | 0 | 0 |
IVERIC BIO INC | COM | 46583P102 | 487 | 30,000 | SH | | SOLE | | 30,000 | 0 | 0 |
JOUNCE THERAPEUTICS INC | COM | 481116101 | 1,550 | 208,559 | SH | | SOLE | | 208,559 | 0 | 0 |
KEROS THERAPEUTICS INC | COM | 492327101 | 396 | 10,000 | SH | | SOLE | | 10,000 | 0 | 0 |
KURA ONCOLOGY INC | COM | 50127T109 | 1,060 | 56,614 | SH | | SOLE | | 56,614 | 0 | 0 |
LEAP THERAPEUTICS INC | COM | 52187K101 | 2,486 | 620,000 | SH | | SOLE | | 620,000 | 0 | 0 |
LUCIRA HEALTH INC | COM | 54948U105 | 1,678 | 220,758 | SH | | SOLE | | 220,758 | 0 | 0 |
MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 | 35 | 49,990 | SH | | SOLE | | 49,990 | 0 | 0 |
MEDICUS SCIENCES ACQUISITION | CL A SHS | G5960S108 | 1,073 | 110,040 | SH | | SOLE | | 110,040 | 0 | 0 |
MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 885 | 365,661 | SH | | SOLE | | 365,661 | 0 | 0 |
MERUS N V | COM | N5749R100 | 7,611 | 345,964 | SH | | SOLE | | 345,964 | 0 | 0 |
MIRATI THERAPEUTICS INC | COM | 60468T105 | 8,127 | 45,941 | SH | | SOLE | | 45,941 | 0 | 0 |
MORPHIC HLDG INC | COM | 61775R105 | 3,268 | 57,704 | SH | | SOLE | | 57,704 | 0 | 0 |
NEXTCURE INC | COM | 65343E108 | 4,862 | 721,302 | SH | | SOLE | | 721,302 | 0 | 0 |
OTONOMY INC | COM | 68906L105 | 1,953 | 1,017,048 | SH | | SOLE | | 1,017,048 | 0 | 0 |
POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 552 | 71,729 | SH | | SOLE | | 71,729 | 0 | 0 |
POLYPID LTD | SHS | M8001Q118 | 1,426 | 183,230 | SH | | SOLE | | 183,230 | 0 | 0 |
RAPT THERAPEUTICS INC | COM | 75382E109 | 366 | 11,796 | SH | | SOLE | | 11,796 | 0 | 0 |
RENALYTIX PLC | ADS | 75973T101 | 742 | 37,000 | SH | | SOLE | | 37,000 | 0 | 0 |
RENOVACOR INC | *W EXP 99/99/999 | 75989E114 | 42 | 104,828 | SH | | SOLE | | 104,828 | 0 | 0 |
RESEARCH ALLIANCE CORP II | COM CL A | 760873109 | 4,663 | 473,396 | SH | | SOLE | | 473,396 | 0 | 0 |
SEAGEN INC | COM | 81181C104 | 1,995 | 11,749 | SH | | SOLE | | 11,749 | 0 | 0 |
SERES THERAPEUTICS INC | COM | 81750R102 | 1,913 | 274,833 | SH | | SOLE | | 274,833 | 0 | 0 |
SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 3,584 | 163,486 | SH | | SOLE | | 163,486 | 0 | 0 |
SOCIAL CAP SUVRETTA HLD CRPI | CLASS A ORD SHS | G8253W109 | 1,039 | 106,000 | SH | | SOLE | | 106,000 | 0 | 0 |
SOCIAL CAP SUVRETTA HLDS CP | CLASS A ORD SHS | G8253Y105 | 1,040 | 106,000 | SH | | SOLE | | 106,000 | 0 | 0 |
SOCIAL CAP SUVRETTA HLDS CRP | CLASS A ORD SHS | G8253T106 | 1,055 | 106,000 | SH | | SOLE | | 106,000 | 0 | 0 |
SOCIAL CAP SUVRETTA HLDS CRP | CLASS A ORD SHS | G8253U103 | 1,047 | 106,000 | SH | | SOLE | | 106,000 | 0 | 0 |
STEREOTAXIS INC | COM NEW | 85916J409 | 1,569 | 291,696 | SH | | SOLE | | 291,696 | 0 | 0 |
SURFACE ONCOLOGY INC | COM | 86877M209 | 379 | 50,000 | SH | | SOLE | | 50,000 | 0 | 0 |
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 3,911 | 21,189 | SH | | SOLE | | 21,189 | 0 | 0 |
VERACYTE INC | COM | 92337F107 | 8,340 | 179,548 | SH | | SOLE | | 179,548 | 0 | 0 |
VIEWRAY INC | COM | 92672L107 | 1,334 | 185,035 | SH | | SOLE | | 185,035 | 0 | 0 |
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 1,745 | 106,078 | SH | | SOLE | | 106,078 | 0 | 0 |
VISTAGEN THERAPEUTICS INC | COM NEW | 92840H202 | 1,939 | 707,733 | SH | | SOLE | | 707,733 | 0 | 0 |
XENON PHARMACEUTICALS INC | COM | 98420N105 | 297 | 19,432 | SH | | SOLE | | 19,432 | 0 | 0 |
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 1,590 | 23,855 | SH | | SOLE | | 23,855 | 0 | 0 |